Cite
HARVARD Citation
Robert, S. et al. (n.d.). 1ISG-001 Can rivaroxaban become cost saving compared with vitamin K antagonists in the treatment of patients with non-valvular atrial fibrillation in France?. European journal of hospital pharmacy. p. A1. [Online].